Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Matloff

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The American Journal of Bioethics : AJOB|August 30, 2008
Direct to confusion: lessons learned from marketing BRCA testingEllen Matloff, Arthur Caplan
JAMA|February 25, 2005
Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situElizabeth B Claus, Stacey Petruzella, Ellen Matloff, et al.
Genetics Research|March 8, 2016
Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendationsJames Ziai, Ellen Matloff, Jaehyuk Choi, et al.
The Breast Journal|February 1, 2017
Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer PatientsKimberly DeLeonardis, Kristin Sedgwick, Olga Voznesensky, et al.
BMC Cancer|October 14, 2021
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test resultsDeborah Cragun, Jason Beckstead, Meagan Farmer, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2026
Challenges and Errors in Genetic Testing: The Sixth Case SeriesMeagan Farmer, Claire McDonald, Darcy K Berry, et al.
Lancet (London, England)|May 4, 2002
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 statusBruce G Haffty, Elizabeth Harrold, Atif J Khan, et al.
The New England Journal of Medicine|May 25, 2002
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Henry T Lynch, et al.
American Journal of Human Genetics|July 5, 2003
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathwayXiao-Ping Zhou, Kristin A Waite, Robert Pilarski, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The American Journal of Bioethics : AJOB|August 30, 2008
Direct to confusion: lessons learned from marketing BRCA testingEllen Matloff, Arthur Caplan
JAMA|February 25, 2005
Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situElizabeth B Claus, Stacey Petruzella, Ellen Matloff, et al.
Genetics Research|March 8, 2016
Defining the polyposis/colorectal cancer phenotype associated with the Ashkenazi GREM1 duplication: counselling and management recommendationsJames Ziai, Ellen Matloff, Jaehyuk Choi, et al.
The Breast Journal|February 1, 2017
Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer PatientsKimberly DeLeonardis, Kristin Sedgwick, Olga Voznesensky, et al.
BMC Cancer|October 14, 2021
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test resultsDeborah Cragun, Jason Beckstead, Meagan Farmer, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2026
Challenges and Errors in Genetic Testing: The Sixth Case SeriesMeagan Farmer, Claire McDonald, Darcy K Berry, et al.
Lancet (London, England)|May 4, 2002
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 statusBruce G Haffty, Elizabeth Harrold, Atif J Khan, et al.
The New England Journal of Medicine|May 25, 2002
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Henry T Lynch, et al.
American Journal of Human Genetics|July 5, 2003
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathwayXiao-Ping Zhou, Kristin A Waite, Robert Pilarski, et al.
Pageof 2